Associate Professor
Microbiology and Immunology | Faculty of Science
Scientific Director | Facility for Infectious Disease and Epidemic Research (FINDER)
Team Leader | NCE IC-IMPACTS Grant in Next Generation Molecular Diagnostics for Emerging Viral Diseases (2014-2017)
Research Interests:

The research programs of my laboratory are based on my breakthroughs in the field of broad-based antiviral therapeutics (Senior, K., 2000. Early steps towards a broad-based antiviral drug. The Lancet 355: 729). My lab is exploring in detail how our novel therapeutic approaches can combat human viral infections using our recently identified protein-based inhibitors directed at those host-cell proteases and viral proteases that are essential for the virus life cycle. I am now expanding the scope of my research to include our newly discovered marine natural products, natural broad-spectrum antiviral peptides, and therapeutic microRNAs. My team is developing and applying novel efficacious broad-based antiviral agents against important human enveloped viruses of major public health concern in Canada and around the world [e.g., hepatitis C virus (HCV), West Nile virus (WNV), dengue virus (DNV), HIV-1, and influenza A virus (InfA)]. My research programs are supported by the Canadian Institutes of Health Research (CIHR) and infrastructure funds from the Canada Foundation for Innovation (CFI) and British Columbia Knowledge Development Fund (BCKDF).